TABLE 6.
Organ recovery |
|||
---|---|---|---|
Organ | SARS-CoV-2 donor status | Study period |
|
March 2020–November 2020 | December 2020–August 2021 | ||
Kidney | Negative | 12 730 (95.4%) | 18 092 (95.5%) |
Positive | 38 (94.7%) | 496 (96.2%) | |
Liver | Negative | 6280 (77.5%) | 9319 (74.3%)* |
Positive | 20 (60%) | 242 (60.7%)* | |
Heart | Negative | 5755 (35.7%) | 8340 (34.4%)* |
Positive | 18 (44.4%) | 239 (22.6%)* |
Organ discard |
|||
---|---|---|---|
Organ | SARS-CoV-2 donor status | Study period (n, [% discard]) |
|
March 2020–November 2020 | December 2020–August 2021 | ||
Kidney | Negative | 12 143 (19.7%)* | 18 092 (22.6%)* |
Positive | 36 (44.4%)* | 477 (28.3%)* | |
Liver | Negative | 4865 (9.2%) | 6922 (9.7%) |
Positive | 12 (8.3%) | 147 (7.5%) | |
Heart | Negative | 2054 (0.9%) | 2845 (1.0%) |
Positive | 8 (0%) | 54 (0%) |
Abbreviation: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
p < .05 for chi-square test for the association of proportion of recovery and discard by SARS-CoV-2 status within each era.